GRP
ZBIO

Global Retirement Partners’s Zenas BioPharma ZBIO Stock Holding History

Global Retirement Partners’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$399 Sell
11
-4
-27% -$132 ﹤0.01% 4036
2025
Q3 		$333 Buy
+15
New +$244 ﹤0.01% 3693

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Global Retirement Partners's ZBIO Position: Q4 2025 in Review

Global Retirement Partners reduced its Zenas BioPharma (ZBIO) stake by 27% in Q4 2025, selling an estimated $132 and leaving 11 shares worth $399. The position accounts for ﹤0.01% of the portfolio, ranked #4036.

Global Retirement Partners first reported a position in ZBIO in Q3 2025 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold ZBIO as of Q4 2025.

  • Global Retirement Partners held 11 shares of Zenas BioPharma worth $399 as of Q4 2025.
  • Global Retirement Partners sold 4 Zenas BioPharma shares in Q4 2025, an estimated $132.
  • Zenas BioPharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #4036 holding.
  • Global Retirement Partners first reported a position in Zenas BioPharma in Q3 2025 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held Zenas BioPharma as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.